"The U.S. Food and Drug Administration today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.
Emend Injection Patient Information including How Should I Take
In this Article
- What is fosaprepitant (Emend Injection)?
- What are the possible side effects of fosaprepitant (Emend Injection)?
- What is the most important information I should know about fosaprepitant (Emend Injection)?
- What should I discuss with my health care provider before I receive fosaprepitant (Emend Injection)?
- How is fosaprepitant given (Emend Injection)?
- What happens if I miss a dose (Emend Injection)?
- What happens if I overdose (Emend Injection)?
- What should I avoid while receiving fosaprepitant (Emend Injection)?
- What other drugs will affect fosaprepitant (Emend Injection)?
- Where can I get more information?
What should I discuss with my health care provider before I receive fosaprepitant (Emend Injection)?
You should not use this medication if you are allergic to fosaprepitant, aprepitant (oral Emend).
The following drugs should not be used while you are receiving fosaprepitant:
- cisapride (Propulsid); or
- pimozide (Orap).
To make sure you can safely take fosaprepitant, tell your doctor if you have liver disease.
Fosaprepitant can make birth control pills less effective, resulting in pregnancy. This effect can last for up to 28 days after your last dose of this medication. Talk to your doctor about the use of a non-hormonal back-up form of birth control (such as condoms, a diaphragm, or spermicides) during treatment with fosaprepitant and for at least 1 month after your treatment ends.
FDA pregnancy category B. Fosaprepitant is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while you are being treated with fosaprepitant.
It is not known whether fosaprepitant passes into breast milk or if it could harm a nursing baby. Before you receive this medication, tell your doctor if you are breast-feeding a baby.
How is fosaprepitant given (Emend Injection)?
Fosaprepitant is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. Fosaprepitant must be given slowly, and the IV infusion can take at least 15 minutes to complete.
The first dose of fosaprepitant is usually given 30 minutes before your chemotherapy treatment begins.
You may also be given other medicines, including oral Emend (aprepitant capsules), for 3 or 4 days to further help prevent nausea and vomiting.
Fosaprepitant is not for long-term use.
Additional Emend Injection Information
Emend Injection - User Reviews
Emend Injection User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.